Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor-T cell therapy

Jabour Halloun; Itay Maza; Anat Stern; Israel Henig; Luiza Akria; Yaniv Zohar; Tsila Zuckerman; Ofrat Beyar-Katz

doi:10.1111/jcmm.18538

Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor-T cell therapy

J Cell Mol Med. 2024 Jul;28(14):e18538. doi: 10.1111/jcmm.18538.

Authors

Jabour Halloun¹, Itay Maza^{2

3}, Anat Stern^{3

4}, Israel Henig^{1

3}, Luiza Akria^{5

6}, Yaniv Zohar^{3

7}, Tsila Zuckerman^{1

3}, Ofrat Beyar-Katz^{1

3}

Affiliations

¹ Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² Gastroenterology Unit, Rambam Health Care Campus, Haifa, Israel.
³ The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
⁴ Division of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
⁵ Hematology and blood bank, Galil Medical Center, Nahariya, Israel.
⁶ Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel.
⁷ Department of pathology, Rambam Health Care Campus, Haifa, Israel.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Colitis* / complications
Colitis* / therapy
Colitis* / virology
Cytomegalovirus Infections* / complications
Cytomegalovirus Infections* / immunology
Cytomegalovirus Infections* / therapy
Cytomegalovirus Infections* / virology
Cytomegalovirus* / pathogenicity
Gastrointestinal Hemorrhage* / etiology
Gastrointestinal Hemorrhage* / therapy
Humans
Immunotherapy, Adoptive / adverse effects
Immunotherapy, Adoptive / methods
Male
Middle Aged
Receptors, Chimeric Antigen / immunology

Substances

Receptors, Chimeric Antigen